Summary
True Data operates a single-segment data marketing business leveraging consumer purchase big data and AI, centered on a recurring revenue model. The company revised its full-year guidance downward concurrently with its 3Q results announcement (revenue: JPY 2B → JPY 1.83B; operating income: JPY 160M → JPY 60M), making the achievability of the revised targets the primary focus for the 4Q print. While the 3Q cumulative operating income guidance achievement rate stood at a solid 83.9%, the company needs to deliver JPY 507M in 4Q revenue (our estimate), making the vertical rollout of Retail DX services for major retailers and the materialization of benefits from the business alliance with Arata and others critical. Monetization of purchase data is diversifying at an accelerating pace—through the launch of a CVC business and advertising data integration with MBK Digital, among others—making this a pivotal quarter that tests the company's distinctiveness as a platform player beyond a simple SaaS tool provider.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
Revenue GrowthAchievement of revised 4Q standalone revenue target | JPY 507M in 4Q revenue required (our estimate). 3Q standalone came in at approx. JPY 456M (our estimate), representing a high hurdle even accounting for seasonality |
ProfitabilityFull-year OPM landing | 3Q cumulative OPM of 3.8% vs. the revised guidance of 3.3%. Whether 4Q standalone operating income of JPY 10M (our estimate) can be secured depends on the extent of upfront costs |
Recurring RevenueEagle Eye contract count | Watch the net addition pace of new Eagle Eye contracts |
Business ExpansionRevenue contribution from various collaboration partners | Watch the ramp-up speed of new revenue domains in daily necessities/cosmetics and retail media advertising |
Investment StrategyCVC investment progress and equity stake trajectory | Investments in securities rose to JPY 55M at 3Q-end (+121.8% vs. prior FY-end). Quality of investees and future business synergies will shape medium-to-long-term enterprise value |
Capital EfficiencyROE improvement trend | Company-implied ROE of approx. 4% (our estimate) remains low. The pace of clearing JPY 459M in accumulated losses and accelerating earnings growth are essential for sustained capital efficiency improvement |
Key Issues from Previous Results (FY2026/3 3Q)
3Q cumulative revenue of JPY 1.323B (+16.9%) maintained double-digit top-line growth, but operating income of JPY 50M (+20.8%) fell short relative to the pre-revision full-year target (JPY 160M), prompting a same-day downward revision to full-year guidance. With COGS ratio at 43.0% (vs. 41.9% in the year-ago period) and SG&A ratio at 53.2% (vs. 54.5%), the pattern of upfront investment absorbing top-line growth persists—raising the question of whether the company can pivot from "quantity of growth" to "quality of growth."
1. Background to Guidance Downward Revision and 4Q Achievability
- Prior Quarter: 3Q cumulative revenue of JPY 1.323B against the revised full-year target of JPY 1.83B. JPY 507M in 4Q standalone revenue is required (our estimate)
- This Quarter Focus: Whether the delayed large contract books revenue within 4Q. Also watch the nature of the contract and customer profile (retailer vs. manufacturer)
- Key Metric: 4Q standalone revenue YoY (prior-year 4Q was JPY 422M (our estimate); +20.1% growth required)
2. Progress in Expanding the Recurring Revenue Base
- Prior Quarter: Vertical rollout of the Retail DX service delivered to a major retailer in the previous quarter contributed to results. Contract liabilities stood at JPY 94M (3Q-end)
- This Quarter Focus: Net addition pace of new Eagle Eye contracts; whether ARR (Annual Recurring Revenue) is disclosed
- Key Metric: FY-end contract liabilities balance (increase from JPY 90M at prior FY-end serves as a proxy for recurring revenue momentum)
3. Revenue Domain Expansion via Arata Alliance and MBK Digital Partnership
- Prior Quarter: The Arata alliance strengthened retail-facing analytics and proposal capabilities. The MBK Digital partnership commenced in November 2025
- This Quarter Focus: Whether specific revenue contributions from each partnership have materialized, and pipeline status
- Key Metric: Standalone/partnership contract counts; growth trend in new customer acquisitions (FMCG manufacturers / daily necessities & cosmetics manufacturers)
4. Impact of Upfront Investment on Cost Structure
- Prior Quarter: 3Q cumulative OPM at 3.8% (vs. 3.7% in the year-ago period)—only marginal improvement. Depreciation of JPY 48M represents 3.7% of revenue
- This Quarter Focus: Whether additional upfront costs are incurred in 4Q. Headcount growth pace and disclosure of productivity metrics
- Key Metric: Achievability of full-year OPM of 3.3% (company target); gross profit margin improvement trend
5. CVC Business Launch and Medium-to-Long-Term Growth Strategy
- Prior Quarter: Investments in securities increased by JPY 30M vs. prior FY-end (+121.8%). JPY 2M in investment partnership operating losses booked as non-operating expenses
- This Quarter Focus: Specific business areas of CVC investees and disclosure of synergy plans with the company's services
- Key Metric: Additional investment deployment; trajectory of investment partnership operating gains/losses; investment return targets in the medium-term management plan
Timely Disclosure & Industry Trends
- 2026/02/12Launch of CVC business specializing in purchase data × AI — A new growth investment aimed at enhancing medium-to-long-term enterprise value through strategic partnerships with AI startups. Watch the pace of investment deployment and business synergies with investees. True Data Official Press Release
- 2026/02/12Notice regarding revision of guidance — Full-year revenue revised from JPY 2B to JPY 1.83B, operating income from JPY 160M to JPY 60M. Primary drivers were delays in ramping up a large contract and front-loaded costs. Notice Regarding Revision of Guidance
- 2025/12/18Strategic business alliance with Arata — Strengthening data-driven solution offerings for the daily necessities/cosmetics industry. Expect channel expansion through joint deployment of Shopping Scan and other initiatives. True Data Official Press Release
- 2025/11/12Data integration with MBK Digital's ad solution "POS Impact Ads" — Through partnership with Mitsui & Co. Group, expanding into the retail media advertising space leveraging purchase data. True Data Official Press Release
Previous Quarter Results (FY2026/3 3Q Actuals)
True Data operates a data marketing business leveraging consumer purchase big data (ID-POS/POS) from retail stores including drugstores and supermarkets, combined with AI, to drive revenue growth for retailers and FMCG manufacturers. Centered on the flagship Eagle Eye service, the company is building a recurring revenue base and pursuing a growth strategy of expanding its customer base through vertical and horizontal rollout of Retail DX and AI solutions. While 3Q cumulative revenue maintained double-digit growth at +16.9%, upfront costs associated with talent investment and AI solution refinement weighed on profitability, limiting operating income growth to +20.8%. Although full-year guidance was revised downward based on 3Q results, the 3Q cumulative guidance achievement rate stands at a broadly solid level—72.3% for revenue and 83.9% for operating income.
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 1.323B | +16.9% | Achievement rate 72.3% | Driven by Eagle Eye contract growth and Retail DX vertical rollout |
| Operating Income | JPY 50M | +20.8% | Achievement rate 83.9% | Upfront costs for talent investment and AI solution refinement weighed on margins |
| Recurring Profit | JPY 56M | +36.9% | Achievement rate 87.5% | - |
| Quarterly Net Income | JPY 40M | +706.1% | Achievement rate 89.8% | Reversal from JPY 26M impairment loss on investment securities in the year-ago period |
| EPS | JPY 8.35 | +695.2% | - | Weighted average shares outstanding: 4,839,514 |
Guidance Achievement Rate (Full-Year): Revenue 63.2% (our estimate), operating income 83.9%
Company Information
- Company Name: True Data Inc.
- Ticker: 4416
- Listed Market: Tokyo Stock Exchange Growth Market
- Fiscal Year-End: March
- Core Business: Data marketing business (single segment) leveraging consumer purchase big data (ID-POS/POS) from retail stores including drugstores and supermarkets, combined with AI and other technologies
Envalith, Inc. ("Envalith") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and Envalith and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. Envalith has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by Envalith using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, Envalith and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. Envalith and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
Envalith and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
Envalith may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that Envalith is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to Envalith. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of Envalith is strictly prohibited.
- Use for Other Investment Products
Except where Envalith has provided prior written approval, the use of this report and the trademarks or trade names of Envalith or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.